Inoue K, Shimada H, Ueba J, Enomoto S, Tanaka-Saisaka Y, Kubota T, Koyama M, Morita T
Department of Biochemistry, Meiji College of Pharmacy, Yato-cho, Tanashi, Tokyo, Japan.
Biochemistry. 1996 Oct 29;35(43):13826-32. doi: 10.1021/bi960713n.
The calcium-mediated interaction of factor VIIa with tissue factor is considered to be the primary trigger of blood coagulation. To determine the role of calcium ions in the action of factor VII, we prepared monoclonal antibodies whose binding to factor VII was calcium-dependent. A monoclonal antibody designated C6 strongly inhibited factor VII-induced clotting at a molar ratio of factor VII to antibody of 1:1. The half-maximal binding of factor VII to the C6 antibody was observed at a concentration of calcium ions of 80 microM. Proteolytic fragments of factor VII were assayed for their ability to inhibit competitively the binding of 125I-factor VII to immobilized C6 antibody. The binding was inhibited by increasing amounts of factor VII, by a fragment that contained the gamma-carboxyglutamic acid (Gla) domain linked to first epidermal growth factor-like domain, and by a Gla domain peptide (residues 1-41), over a range of concentration of 10(-9) to 10(-7) M. The antigenic site recognized by the monoclonal antibody C6, which was generated upon the high-affinity binding of calcium ions, was located in the Gla domain. The C6 antibody inhibited the activation of factor X and the amidolytic activity of factor VIIa in the presence of tissue factor. These results demonstrate that a high-affinity calcium-binding site(s) is located in the Gla domain of factor VII, which is concerned with the initiation of tissue factor-mediated blood coagulation by factor VIIa.
凝血因子VIIa与组织因子的钙介导相互作用被认为是血液凝固的主要触发因素。为了确定钙离子在凝血因子VII作用中的角色,我们制备了与凝血因子VII的结合依赖于钙的单克隆抗体。一种名为C6的单克隆抗体在凝血因子VII与抗体的摩尔比为1:1时强烈抑制凝血因子VII诱导的凝血。在钙离子浓度为80微摩尔时观察到凝血因子VII与C6抗体的半数最大结合。检测了凝血因子VII的蛋白水解片段竞争性抑制125I-凝血因子VII与固定化C6抗体结合的能力。在10^(-9)至10^(-7)M的浓度范围内,随着凝血因子VII量的增加、含有与第一个表皮生长因子样结构域相连的γ-羧基谷氨酸(Gla)结构域的片段以及Gla结构域肽(第1至41位残基)的增加,结合受到抑制。单克隆抗体C6识别的抗原位点位于Gla结构域,该位点是在钙离子的高亲和力结合后产生的。C6抗体在存在组织因子的情况下抑制凝血因子X的激活和凝血因子VIIa的酰胺水解活性。这些结果表明,高亲和力钙结合位点位于凝血因子VII的Gla结构域,这与凝血因子VIIa启动组织因子介导的血液凝固有关。